Best Life Sciences Companies in New Mexico, United States

Provider of bio informatics platform to develops biologics and therapeutics. The company offers NTxscribe and NTxpress technologies that enable high-throughput screening and fast prototyping of novel biological materials with defined qualities. NTxscribe delivers high quality, high integrity conventional mRNA and long saRNA compatible for use with modified nucleotides. In addition to cell-free production, NTx offers real-time metabolic profiling of bacteria, fungi, and plants to discover, characterize and ultimately produce new chemical entities (NCEs) and biosimilars.

Funding rounds

• Nov 2025Series B$10.4M
• May 2025Series B$4.2M
• Dec 2024Venture Debt$15M
• Nov 2023Series B$47.5M

Founders & team

Alexander KoglinCo-FounderMichael HumbertCo-Founder

Investors

New Mexico Economic Development Department, Anzu Partners, Gates, RA Capital Management, J P Morgan, Camino Real Capital Partners

Tech stack

AosCart FunctionalityCloudflareCloudflare Bot ManagementCore-JsGenesis Theme

Digital care planning and health monitoring tool for professionals. It provides emergency response and monitoring for aging, ill and disabled people. It provides alarms that send a message to the concerned care providers and family members and medical alert buttons that are placed throughout the residence for summoning help when needed. It also monitors fire and carbon monoxide danger and provides a response when medication or sensory impairments put loved ones at risk.

Provider of RNA-based diagnostics and therapeutics to treat depression. The company has developed a circular RNA-based genomic assay as a biomarker that provides a therapeutic response for individuals with psychiatric and neurological conditions.

Provider of machine learning-based bioinformatics solutions. It uses bioinformatics and machine learning to provide deep insights into users' or customers' health and well-being. It helps in providing meaningful insights from this data to inform users on how to change their behavior and diet to live healthier lives. It also offers a kit "Gut Intelligence" for providing gut microbiome tests.

Developer of long-read DNA sequencing technology for precision medicine. The technology used is a nanopore-based sequencing technique for enabling the detection of genome variations. It enables clinicians to provide precision medicine.

VisionQuest Biomedical develops diagnostic devices for ophthalmic diseases and diabetic complications. Its platform technology EyeStar is an imaging software that is used for the automated diagnosis of diabetic retinopathy, and is compatible with existing retinal cameras. Another software ASPIRE is used in conjunction with existing retinal cameras for the diagnosis of malarial retinopathy. VisionQuest is also developing a device for the early diagnosis of diabetic neuropathy.

Developer of nanoparticle-based drug delivery systems. It designs and develops a drug delivery system for the delivery of therapeutic RNAs and small-molecule drugs to specific cell targets.

Funding rounds

• Sep 2025Seed$2.4M
• Feb 2025Seed—
• Mar 2024Seed$150K
• Aug 2023Seed$2M

Founders & team

Bruce McCormickCEO

Developer of surgical monitoring devices for laparoscopic and robotic procedures. The product is Perf-Alert a system designed to detect bowel gas or injury in real time during surgery and alert surgeons immediately so they can fix issues on the spot.

Funding rounds

• Dec 2025Seed$1.2M
• Jan 2023Grant (prize money)$256K
• May 2020Grant (prize money)$225K
• Jan 2018Seed$600K

Founders & team

Balakrishna HaridasCo-FounderDavid KrasneCo-Founder & CEO

Investors

America’s Seed Fund, National Science Foundation, ShangBay Capital

Tech stack

Squarespace CommerceSquarespaceHstsOpen Graph

Developer of a federated learning and edge-computing platform designed to allow artificial intelligence (AI) /data-science developers to collaborate without sharing data or compromising data privacy. The company's platform uses federated learning and distributed computing technologies, using which artificial intelligence (AI) models can quickly and continuously improve by learning from each new dataset and applying those learnings to the next, without requiring costly and risky data transfers, thereby helping users to accelerate creation and training of more accurate artificial intelligence (AI) models that work consistently across different patient populations, leading to more widespread adoption of advanced healthcare solutions.

Pioneering respiratory patient care through innovative inhalation medicine technologies. This company focuses on re-envisioning inhalation medicines and their delivery to the lungs, aiming to transform the treatment of high-dose lung delivery. They are developing new technologies and therapies for lung-related diseases that are currently difficult to treat. Their mission is centered around improving patients' lives through advancements in respiratory care. They are committed to delivering results, acting pragmatically, moving fast, fostering trust and support, and doing the right thing. This is a B2B tech company focused on medical devices and respiratory therapies.

{}

Funding rounds

• Sep 2024Grant (prize money)$295.3K
• Feb 2016Grant (prize money)$2.1M
• Jul 2014Grant (prize money)$150K

Founders & team

Alexander UkhanovOwner

Investors

OSTI

Tech stack

WordpressMysqlPhpGoogle MapsHello ElementorElementor

Provider of sampling, detection, and identification products. The flagship products of the company are fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Also, it develops Handheld Air Sampler for SARS-CoV-2 detection.